13
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T7657 | Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat | MOG (35-55) | Others |
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (MOG (35-55)) is a truncated peptide derived from the human Myelin Oligodendrocyte Glycoprotein (MOG). | |||
T7657L | MOG peptide (35-55) , mouse, rat acetate | Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat acetate,MOG peptide (35-55) , mouse, rat acetate (149635-73-4 Free base) | Others |
Myelin Oligodendrocyte Glycoprotein (MOG) peptide (35-55) , mouse, rat acetate is a MOG peptide (35-55) derivative. MOG peptide (35-55) is a part of myelin oligodendrocyte glycoprotein (MOG) immunogenic peptide and can b... | |||
T83695 | MOG Peptide (human, bovine) acetate | Myelin Oligodendrocyte Glycoprotein Peptide | |
Myelin oligodendrocyte glycoprotein (MOG) peptide, a truncated form of MOG located on the extracellular myelin sheath surface, interacts with antigen serotype HLA-DR2 to mitigate effects of ischemic stroke induced by mid... | |||
T78541 | Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA | MOG (35-55) (TFA) | |
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (MOG (35-55)) TFA, a minor constituent of central nervous system (CNS) myelin, demonstrates encephalitogenic properties by inducing T cell proliferation and... | |||
T78542 | Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat acetate | MOG (35-55) (acetate) | |
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (MOG (35-55)) acetate, a minor component of CNS myelin, exhibits encephalitogenic activity by inducing T cell proliferation and a Th1 cytokine response, alo... | |||
TP1091 | MOG (35-55) (TFA) (149635-73-4 free base) | MOG (35-55) (TFA),Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA | |
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (TFA) is a minor component of CNS myelin. | |||
T39671 | MOG (89-113), human | ||
MOG (89-113), human is a peptide fragment of human myelin oligodendrocyte glycoprotein. | |||
T81771 | MOG peptide (79-96) rat | ||
MOG peptide (35-55) rat, a segment of myelin oligodendrocyte glycoprotein (MOG), exhibits encephalitogenic properties [1]. | |||
T78031 | MOG peptide (35-55) | ||
MOG peptide (35-55), a myelin oligodendrocyte glycoprotein (MOG) fragment spanning amino acids 35 to 55, selectively stimulates CD4+ T cell expansion and induces experimental autoimmune encephalomyelitis (EAE) in animal ... | |||
T81772 | MOG (92–106), mouse, rat | ||
MOG (92–106), mouse, rat, is a biologically active peptide corresponding to the fragment of amino acids 92 to 106 in myelin oligodendrocyte glycoprotein (MOG) from mice and rats. It is noteworthy that mice subjected to M... | |||
T83690 | [Leu144, Arg147]-PLP (139-151) TFA | [Leu144, Arg147] Proteolipid Peptide (139-151),H-His-Ser-Leu-Gly-Lys-Leu-Leu-Gly-Arg-Pro-Asp-Lys-Phe-OH | |
[Leu144,Arg147]-PLP (139-151) is a mutated fragment of the myelin proteolipid protein (PLP), featuring substitutions of tryptophan to leucine and histidine to arginine at positions 144 and 147, respectively. Immunizing m... | |||
T83910 | S1PL-IN-31 | Sphingosine-1-Phosphate Lyase Inhibitor 31,S1PL Inhibitor 31,S1P Lyase Inhibitor 31 | |
S1PL-IN-31 is a dual-function chemical compound acting as an inhibitor of sphingosine-1-phosphate (S1P) lyase with an IC50 value of 210 nM and as an antagonist of the Smoothened (Smo) receptor with an IC50 of 440 nM. Dem... | |||
T38106 | JC-171 | ||
JC-171, a selective inhibitor of the NLRP3 inflammasome, effectively inhibits LPS/ATP-induced interleukin-1β (IL-1β) release from J774A.1 macrophages with an IC50 of 8.45 μM[1]. |